Eastman Chemical Company (EMN)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-05
$65.71-2.81%
Close 2026-11-05 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-05
QuarterlyIQ Insights · EMN
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within materials on a research-validated quality screen. As of 2026-11-05.
The screen ranks EMN against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 3 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Materials names rated neutral grew net income 46% of the time over the next year (vs 56% for the rest of the cohort, n=2600).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Met or beat guidance 25% of the last 4 guided quarters · -2.3% avg surprise
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
In this context, we remained focused on our disciplined approach toward cost savings, and we remain on track to reduce costs by $125 million to $150 million, net of inflation in 2026.
Stated in 4 of 4 supplied quarters. Management reported: “In this context, we remained focused on our disciplined approach toward cost savings, and we remain on track to reduce costs by $125 million to $150 million, net of inflation in 2026.” “We also remain on track to reduce costs between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year.”
“In this context, we remained focused on our disciplined approach toward cost savings, and we remain on track to reduce costs by $125 million to $150 million, net of inflation in 2026.”
“We also remain on track to reduce costs between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year.”
“We remain on track to reduce costs by between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year.”
“First, we are increasing our cost structure reduction actions to a range of $125 million to $150 million, building upon the actions already taken in 2025.”
Higher selling prices across the company were primarily driven by higher raw material and distribution costs as well as tight market conditions in Chemical Intermediates due to the ongoing conflict i…
Stated in 4 of 4 supplied quarters. Management reported: “Higher selling prices across the company were primarily driven by higher raw material and distribution costs as well as tight market conditions in Chemical Intermediates due to the ongoing conflict in the Middle East.” “A key contributor to our innovation-driven growth is our Kingsport methanolysis facility, which continues to build strategic momentum.”
We also continue to emphasize the importance of operating cash flow in this dynamic environment.”
Stated in 4 of 4 supplied quarters. Management reported: “We also continue to emphasize the importance of operating cash flow in this dynamic environment.”” “As a result, we now expect operating cash flow to approach $900 million, which is modestly below our previous expectation of approaching 2025 levels.”
“We also continue to emphasize the importance of operating cash flow in this dynamic environment.””
We also remain on track to reduce costs between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year.
Stated in 3 of 4 supplied quarters. Management reported: “See Table 5. Priorities for uses of available cash for 2026 include payment of the quarterly dividend, capital expenditures, and maintaining our solid investment-grade balance sheet.” “We also remain on track to reduce costs between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year.”
Use innovation to support growth across specialty businesses, including in weak discretionary end markets.
Over the trailing year it converted 0.17x of net income into operating cash flow. Historically, Materials names rated fragile grew net income 46% of the time over the next year (vs 53% for the rest of the cohort, n=1429).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
7 material management or governance events in the past 24 months, led by executive changes. Historically, Materials names rated stable grew net income 57% of the time over the next year (vs 51% for the rest of the cohort, n=1843).
Not investment advice. As of 2026-11-05.
“Higher selling prices across the company were primarily driven by higher raw material and distribution costs as well as tight market conditions in Chemical Intermediates due to the ongoing conflict i…”
“A key contributor to our innovation-driven growth is our Kingsport methanolysis facility, which continues to build strategic momentum.”
“We expect meaningful growth from our innovation-driven growth model, led by new wins in our Renew product lines produced at our Kingsport methanolysis facility.”
“Second, we continue to benefit from our innovation model creating growth with the largest driver being our methanolysis facility.”
“As a result, we now expect operating cash flow to approach $900 million, which is modestly below our previous expectation of approaching 2025 levels.”
“We see a pathway for operating cash flow to approach 2025 levels while recognizing that this pathway is narrowing in the current environment.”
“With these assumptions, we also expect operating cash flow to be similar to 2025.”
“We also remain on track to reduce costs between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year.”
“We remain on track to reduce costs by between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year.”
“See Table 5. Priorities for uses of available cash in 2026 include payment of the quarterly dividend, capital expenditures, and share repurchases, while maintaining our solid investment-grade balance…”